Integrated multiomic approach for identification of novel immunotherapeutic targets in AML.

Köhnke, Thomas; Liu, Xilong; Haubner, Sascha; Bücklein, Veit; Hänel, Gerulf; Krupka, Christina; Solis-Mezarino, Victor; Herzog, Franz; Subklewe, Marion

Köhnke, Thomas; Liu, Xilong; Haubner, Sascha; Bücklein, Veit; Hänel, Gerulf; Krupka, Christina; Solis-Mezarino, Victor; Herzog, Franz; Subklewe, Marion.

Afiliação

Köhnke T; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.
Liu X; Laboratory for Translational Cancer Immunology, Gene Center Munich, LMU Munich, Munich, Germany.
Haubner S; Laboratory for Translational Cancer Immunology, Gene Center Munich, LMU Munich, Munich, Germany.
Bücklein V; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.
Hänel G; Laboratory for Translational Cancer Immunology, Gene Center Munich, LMU Munich, Munich, Germany.
Krupka C; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.
Solis-Mezarino V; Laboratory for Translational Cancer Immunology, Gene Center Munich, LMU Munich, Munich, Germany.
Herzog F; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.
Subklewe M; Laboratory for Translational Cancer Immunology, Gene Center Munich, LMU Munich, Munich, Germany.

Biomark Res ; 10(1): 43, 2022 Jun 10.

Article em En | MEDLINE | ID: mdl-35681175

Palavras-chave

Acute myeloid leukemia; Immunology; Leukemia; Proteomics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Biomark Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google